1. Home
  2. CASS vs STTK Comparison

CASS vs STTK Comparison

Compare CASS & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cass Information Systems Inc

CASS

Cass Information Systems Inc

N/A

Current Price

$46.41

Market Cap

596.8M

ML Signal

N/A

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

N/A

Current Price

$6.15

Market Cap

538.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CASS
STTK
Founded
1906
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
596.8M
538.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CASS
STTK
Price
$46.41
$6.15
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$45.00
$10.00
AVG Volume (30 Days)
54.5K
539.5K
Earning Date
04-23-2026
05-01-2026
Dividend Yield
2.75%
N/A
EPS Growth
87.77
53.02
EPS
0.67
N/A
Revenue
$190,750,000.00
$1,000,000.00
Revenue This Year
$0.81
N/A
Revenue Next Year
$4.39
N/A
P/E Ratio
$69.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$36.07
$0.71
52 Week High
$52.45
$8.33

Technical Indicators

Market Signals
Indicator
CASS
STTK
Relative Strength Index (RSI) 52.59 45.12
Support Level $45.20 $5.81
Resistance Level $47.93 $6.81
Average True Range (ATR) 1.11 0.44
MACD -0.04 -0.06
Stochastic Oscillator 53.26 32.48

Price Performance

Historical Comparison
CASS
STTK

About CASS Cass Information Systems Inc

Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution, and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. Additionally, the firm has a banking subsidiary, offering banking services mainly to privately held businesses in the St. Louis metropolitan area and restaurant franchises and faith-based ministries within the United States. The company operates in two reportable segments: Information Services, which generates the maximum revenue, and Banking Services.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: